Top Markets
#1 Trillions Trillions +5,128.12%
#2 DeFiChain DeFiChain +1,700.88%
#3 Bedrock Bedrock +165.63%
#4 Siren Siren +128.69%
#5 inSure DeFi inSure DeFi +59.52%
#6 KONET KONET +56.82%
#7 Aria.AI Aria.AI +45.69%
#8 Banana For Scale Banana For Scale +45.24%
#9 Syndicate Syndicate +40.88%
#10 Janction Janction +36.48%
Coin of the day
Trillions Trillions
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
Rang in aandelen #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Aandeelprijs
$0.09933121
Marktkapitalisatie
$29.15K
Verandering (1 dag)
0.57%
Verandering (1 jaar)
449.49%
Land
IE
Handel Ovoca Bio plc (OVB)

Categorie

Healthcare
P/B-ratio voor Ovoca Bio plc (OVB)
P/B-ratio op March 2026 TTM: 0.32
Volgens de meest recente financiële rapporten en aandelenkoers van Ovoca Bio plc is de huidige P/B-ratio (TTM) 0.32. Eind 2022 had het bedrijf een P/B-ratio van 0.64.
P/B-ratiohistoriek voor Ovoca Bio plc van 2001 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
2026 (TTM) 0.32 5.10%
2023 0.30 -53.15%
2022 0.64 -29.64%
2021 0.91 118.10%
2020 0.42 -3.84%
2019 0.43 -6.34%
2018 0.46 53.47%
2017 0.30 -32.59%
2016 0.45 47.37%
2015 0.30 -7.99%
2014 0.33 9.22%
2013 0.30 -0.88%
2012 0.31 -37.76%
2011 0.49 -30.05%
2010 0.70 56.65%
2009 0.45 86.66%
2008 0.24 -82.53%
2007 1.37 8.35%
2006 1.27 -10.71%
2005 1.42 46.67%
2004 0.97 -4.43%
2003 1.01 -25.12%
2002 1.35 -22.97%
2001 1.76 0.00%
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5.6573 1,694.26%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3842 1,924.80%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.4551 678.66%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.364 1,284.08%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 5.9034 1,772.31%
NL